Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer

NCT00001507 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

107

Enrollment

NIH

Sponsor class

Conditions

Breast Neoplasm
Neoplasm Metastasis

Interventions

DRUG: Monoclonal Antibody 3A1
DRUG: Monoclonal Antibody 95-5-49
DRUG: Monoclonal Antibody 95-6-22
DEVICE: Baxter Isolex 3001 Stem Cell Selection System
DEVICE: Ceprate SC

Sponsor

National Cancer Institute (NCI)